Economic considerations in management of complicated urinary tract infections.
O'Leary
M P
MP
Department of Urology, Tufts University School of Medicine, New England Medical Center Hospital, Boston, Massachusetts.
D002939:Ciprofloxacin / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D003428:Cross Infection / Q000188:drug therapy / Q000191:economics; D005260:Female; D006801:Humans; D007902:Length of Stay / Q000191:economics; D008875:Middle Aged; D014552:Urinary Tract Infections / Q000188:drug therapy / Q000191:economics*
D002939:Ciprofloxacin